PAVmed Inc. (PAVM)Healthcare | Medical Devices | New York, United States | NasdaqCM
5.50 USD
-0.10
(-1.786%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 5.39 -0.11 (-0.110%) ⇩ (July 13, 2026, 4:56 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 5:21 a.m. EDT
The immediate outlook is severely compromised by a massive 1-for-30 reverse stock split, which typically signals distress or a desperate attempt to meet listing requirements rather than organic growth. While the stock recently rallied, the underlying reality is stark: the company is burning cash aggressively with negative operating margins of -365% and negative free cash flow. The balance sheet is fragile, carrying debt that exceeds its cash reserves, and the business has failed to generate a single profit over the last eight years. Fundamentally, this is a value trap; the market has already priced in the collapse, evidenced by the nearly 99% drop in share price since 2017 and four consecutive years of declining annual returns. There is no reliable income for investors, as the company has not paid a dividend in five years. Despite some optimistic headlines and analyst upgrades, the deteriorating fundamentals and cash bleed make this a dangerous speculative vehicle rather than a viable investment. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.353150 |
| AutoETS | 0.394014 |
| MSTL | 0.397243 |
| AutoARIMA | 0.404356 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 4.80 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.551 |
| Excess Kurtosis | -0.37 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 68.073 |
| Revenue per Share | 0.089 |
| Market Cap | 39,374,688 |
| Forward P/E | -2.24 |
| Beta | 0.55 |
| Website | https://www.pavmed.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6825397 |
| Address1 | 360 Madison Avenue |
| Address2 | 25th Floor |
| All Time High | 6,858.0 |
| All Time Low | 3.85 |
| Ask | 7.05 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 18,790 |
| Average Daily Volume3 Month | 17,978 |
| Average Volume | 17,978 |
| Average Volume10Days | 18,790 |
| Beta | 0.548 |
| Bid | 3.96 |
| Bid Size | 2 |
| Book Value | 5.705 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.5 |
| Current Ratio | 2.023 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 5.785 |
| Day Low | 5.5 |
| Debt To Equity | 68.073 |
| Display Name | PAVmed |
| Earnings Call Timestamp End | 1,778,848,200 |
| Earnings Call Timestamp Start | 1,778,848,200 |
| Earnings Timestamp | 1,778,848,200 |
| Earnings Timestamp End | 1,786,624,200 |
| Earnings Timestamp Start | 1,786,624,200 |
| Ebitda | -24,313,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.595 |
| Enterprise To Revenue | 456.09 |
| Enterprise Value | 38,767,688 |
| Eps Current Year | -2.62 |
| Eps Forward | -2.45 |
| Eps Trailing Twelve Months | -48.31 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.99586 |
| Fifty Day Average Change | -0.4958601 |
| Fifty Day Average Change Percent | -0.08270041 |
| Fifty Two Week Change Percent | -68.25397 |
| Fifty Two Week High | 28.44 |
| Fifty Two Week High Change | -22.94 |
| Fifty Two Week High Change Percent | -0.8066104 |
| Fifty Two Week Low | 3.85 |
| Fifty Two Week Low Change | 1.6500001 |
| Fifty Two Week Low Change Percent | 0.42857146 |
| Fifty Two Week Range | 3.85 - 28.44 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,469,626,200,000 |
| Float Shares | 5,197,029 |
| Forward Eps | -2.45 |
| Forward P E | -2.2448978 |
| Free Cashflow | -11,418,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 41 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -2.28235 |
| Gross Profits | -194,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.44145 |
| Held Percent Institutions | 0.27521 |
| Implied Shares Outstanding | 7,159,034 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,767,312,000 |
| Last Split Factor | 1:30 |
| Long Business Summary | PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck device. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. |
| Long Name | PAVmed Inc. |
| Market | us_market |
| Market Cap | 39,374,688 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_277974005 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -28,457,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 39,374,687 |
| Number Of Analyst Opinions | 2 |
| Open | 5.58 |
| Operating Cashflow | -6,245,000 |
| Operating Margins | -365.22726 |
| Payout Ratio | 0.0 |
| Phone | 917 813 1828 |
| Post Market Change | -0.11000013 |
| Post Market Change Percent | -2.0000024 |
| Post Market Price | 5.39 |
| Post Market Time | 1,783,976,194 |
| Previous Close | 5.6 |
| Price Eps Current Year | -2.0992367 |
| Price Hint | 2 |
| Price To Book | 0.9640666 |
| Price To Sales Trailing12 Months | 463.23163 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.872 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.099999905 |
| Regular Market Change Percent | -1.7857127 |
| Regular Market Day High | 5.785 |
| Regular Market Day Low | 5.5 |
| Regular Market Day Range | 5.5 - 5.785 |
| Regular Market Open | 5.58 |
| Regular Market Previous Close | 5.6 |
| Regular Market Price | 5.5 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 6,077 |
| Return On Assets | -0.31039 |
| Return On Equity | -0.67221 |
| Revenue Growth | 1.75 |
| Revenue Per Share | 0.089 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 7,159,034 |
| Shares Percent Shares Out | 0.0047 |
| Shares Short | 33,650 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 8,301 |
| Short Name | PAVmed Inc. |
| Short Percent Of Float | 0.0064 |
| Short Ratio | 1.29 |
| Source Interval | 15 |
| State | NY |
| Symbol | PAVM |
| Target High Price | 56.0 |
| Target Low Price | 16.0 |
| Target Mean Price | 36.0 |
| Target Median Price | 36.0 |
| Total Cash | 6,839,000 |
| Total Cash Per Share | 0.955 |
| Total Debt | 17,010,000 |
| Total Revenue | 85,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -48.31 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 9.31874 |
| Two Hundred Day Average Change | -3.81874 |
| Two Hundred Day Average Change Percent | -0.40979144 |
| Type Disp | Equity |
| Volume | 6,077 |
| Website | https://www.pavmed.com |
| Zip | 10,017 |